BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27258730)

  • 1. A Reappraisal of the Incidence of Placental Hydatidiform Mole Using Selective Molecular Genotyping.
    Colgan TJ; Chang MC; Nanji S; Kolomietz E
    Int J Gynecol Cancer; 2016 Sep; 26(7):1345-50. PubMed ID: 27258730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P57
    Awosusi BL; Ajani MA; Adegoke OO; Salami AA; Okolo CA
    Niger Postgrad Med J; 2020; 27(4):331-335. PubMed ID: 33154286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placental Molar Disease: What are the Benefits and Barriers to the Adoption of a Comprehensive Diagnostic Service?
    Kolomietz E; Maire G; Nanji S; Chang MC; Vlasschaert M; Dodge J; Colgan TJ
    Int J Gynecol Pathol; 2015 Sep; 34(5):411-8. PubMed ID: 25851707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Ki-67 Have a Role in the Diagnosis of Placental Molar Disease?
    Alwaqfi R; Chang MC; Colgan TJ
    Int J Gynecol Pathol; 2020 Jan; 39(1):1-7. PubMed ID: 30394942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of recurrent molar pregnancies following complete and partial hydatidiform moles.
    Eagles N; Sebire NJ; Short D; Savage PM; Seckl MJ; Fisher RA
    Hum Reprod; 2015 Sep; 30(9):2055-63. PubMed ID: 26202916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of hydatidiform mole in a Tokyo hospital: a 5-year (1989 to 1993) prospective, morphological, and flow cytometric study.
    Fukunaga M; Ushigome S; Endo Y
    Hum Pathol; 1995 Jul; 26(7):758-64. PubMed ID: 7628848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and subclassification of hydatidiform moles using p57 immunohistochemistry and molecular genotyping: validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach.
    McConnell TG; Murphy KM; Hafez M; Vang R; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):805-17. PubMed ID: 19145201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreasing incidence of registered hydatidiform moles in Denmark 1999-2014.
    Lund H; Vyberg M; Eriksen HH; Grove A; Jensen AØ; Sunde L
    Sci Rep; 2020 Oct; 10(1):17041. PubMed ID: 33046739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydatidiform mole in Turkey: results from six centers.
    Oge T; Ozalp SS; Güngör T; Yildirim Y; Sanci M; Dogan A; Ertas IE; Yetimalar H; Dilek S; Celik C
    J Reprod Med; 2012; 57(5-6):259-61. PubMed ID: 22696823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of p57
    Madi JM; Braga AR; Paganella MP; Litvin IE; Da Ros Wendland EM
    Syst Rev; 2016 Oct; 5(1):169. PubMed ID: 27716354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydatidiform mole as seen in a university teaching hospital: a 10-year review.
    Audu BM; Takai IU; Chama CM; Bukar M; Kyari O
    J Obstet Gynaecol; 2009 May; 29(4):322-5. PubMed ID: 19835501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal trends in incidence and outcome of hydatidiform mole: a retrospective cohort study.
    Joneborg U; Folkvaljon Y; Papadogiannakis N; Lambe M; Marions L
    Acta Oncol; 2018 Aug; 57(8):1094-1099. PubMed ID: 29451409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinico-pathological study of complete and partial hydatidiform moles in a Nigerian population.
    Osamor JO; Oluwasola AO; Adewole IF
    J Obstet Gynaecol; 2002 Jul; 22(4):423-5. PubMed ID: 12521470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reporting and incidence trends of hydatidiform mole in Sweden 1973-2004.
    Salehi S; Eloranta S; Johansson AL; Bergström M; Lambe M
    Acta Oncol; 2011 Apr; 50(3):367-72. PubMed ID: 21395467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A possible association between hydatidiform mole and the COVID-19 pandemic: A retrospective cohort study.
    Aiob A; Naskovica K; Sharon A; Bornstein J
    Gynecol Oncol; 2021 May; 161(2):454-457. PubMed ID: 33712273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of p57
    Madi JM; Braga A; Paganella MP; Litvin IE; Wendland EM
    BJOG; 2018 Sep; 125(10):1226-1233. PubMed ID: 29782064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic utility of microsatellite genotyping for molar pregnancy testing.
    Furtado LV; Paxton CN; Jama MA; Tripp SR; Wilson AR; Lyon E; Jarboe EA; Thaker HM; Geiersbach KB
    Arch Pathol Lab Med; 2013 Jan; 137(1):55-63. PubMed ID: 23276175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydatidiform mole in Nottingham: a 12-year retrospective epidemiological and morphological study.
    Womack C; Elston CW
    Placenta; 1985; 6(2):93-105. PubMed ID: 4022949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydatidiform mole in Kandang Kerbau Hospital--a 5-year review.
    Chong CY; Koh CF
    Singapore Med J; 1999 Apr; 40(4):265-70. PubMed ID: 10487081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of hydatidiform moles using p57 immunohistochemistry and HER2 fluorescent in situ hybridization.
    LeGallo RD; Stelow EB; Ramirez NC; Atkins KA
    Am J Clin Pathol; 2008 May; 129(5):749-55. PubMed ID: 18426735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.